Cervical cancer survival prediction by machine learning algorithms: a systematic review

Cervical Cancer Detection Using Deep Neural Network and Hybrid Waterwheel Plant Optimization Algorithm

More than 85% of the world's cervical cancer fatalities occur in less-developed nations, causing early mortality among women. In this paper, we propose a novel approach for the early classification of cervical cancer based on a new feature selection algorithm and classification method. The new feature selection algorithm is based on a hybrid of the Waterwheel Plant Algorithm and Particle Swarm Optimization algorithms, and bWWPAPSO denotes it. Meanwhile, the new classification method is based on optimizing the parameters of a multilayer perceptron neural network (WWPAPSO+MLP). A publicly available dataset is employed to verify the effectiveness of the proposed approach. Due to this dataset's imbalance and missing values, it is preprocessed and balanced using SMOTETomek, where undersampling and oversampling were utilized. The usefulness of class imbalance and feature selection based on the classifier's specificity, sensitivity, and accuracy has been demonstrated by way of a comparative study of the proposed methodology that has been carried out. WWPAPSO+MLP achieves superior performance, with an accuracy of 97.3% and a sensitivity of 98.8%. On the other hand, several statistical tests were conducted, including the Wilcoxon signed rank test and analysis of variance (ANOVA) to confirm the effectiveness and superiority of the proposed approach.

CausalCervixNet: convolutional neural networks with causal insight (CICNN) in cervical cancer cell classification-leveraging deep learning models for enhanced diagnostic accuracy

Cervical cancer is a significant global health issue affecting women worldwide, necessitating prompt detection and effective management. According to the World Health Organization (WHO), approximately 660,000 new cases of cervical cancer and 350,000 deaths were reported globally in 2022, with the majority occurring in low- and middle-income countries. These figures emphasize the critical need for effective prevention, early detection, and diagnostic strategies. Recent advancements in machine learning (ML) and deep learning (DL) have greatly enhanced the accuracy of cervical cancer cell classification and diagnosis in manual screening. However, traditional predictive approaches often lack interpretability, which is critical for building explainable AI systems in medicine. Integrating causal reasoning, causal inference, and causal discovery into diagnostic frameworks addresses these challenges by uncovering latent causal relationships rather than relying solely on observational correlations. This ensures greater consistency, comprehensibility, and transparency in medical decision-making. This study introduces CausalCervixNet, a Convolutional Neural Network with Causal Insight (CICNN) tailored for cervical cancer cell classification. By leveraging causality-based methodologies, CausalCervixNet uncovers hidden causal factors in cervical cell images, enhancing both diagnostic accuracy and efficiency. The approach was validated on three datasets: SIPaKMeD, Herlev, and our self-collected ShUCSEIT (Shiraz University-Computer Science, Engineering, and Information Technology) dataset, containing detailed cervical cell cytopathology images. The proposed framework achieved classification accuracies of 99.14%, 97.31%, and 99.09% on the SIPaKMeD, Herlev, and ShUCSEIT datasets, respectively. These results highlight the importance of integrating causal discovery, causal reasoning, and causal inference into diagnostic workflows. By merging causal perspectives with advanced DL models, this research offers an interpretable, reliable, and efficient framework for cervical cancer diagnosis, contributing to improved patient outcomes and advancements in cervical cancer treatment.

Unraveling the Role of PET in Cervical Cancer: Review of Current Applications and Future Horizons

FDG PET/CT provides complementary metabolic information with greater sensitivity and specificity than conventional imaging modalities for evaluating local recurrence, nodal, and distant metastases in patients with cervical cancer. PET/CT can also be used in radiation treatment planning, which is the mainstay of treatment. With the implementation of various oncological guidelines, FDG PET/CT has been utilized more frequently in patient management and prognostication. Newer PET tracers targeting the tumor microenvironment offer valuable biologic insights to elucidate the mechanism of treatment resistance and tumor aggressiveness and identify the high-risk patients. Artificial intelligence and machine learning approaches have been utilized more recently in metastatic disease detection, response assessment, and prognostication of cervical cancer.

A bibliometric review of predictive modelling for cervical cancer risk

Cervical cancer represents a significant public health challenge, particularly affecting women's health globally. This study aims to advance the understanding of cervical cancer risk prediction research through a bibliometric analysis. The study identified 800 records from Scopus and Web of Science databases, which were reduced to 142 unique records after removing duplicates. Out of 100 abstracts assessed, 42 were excluded based on specific criteria, resulting in 58 studies included in the bibliometric review. Multiple scoping methods such as thematic analysis, citation analysis, bibliographic coupling, natural language processing, Latent Dirichlet Allocation and other visualisation techniques were used to analyse related publications between 2013 and 2024. The key findings revealed the importance of interdisciplinary collaboration in cervical cancer risk prediction, integrating expertise from mathematical disciplines, biomedical health, healthcare practitioners, public health, and policy. This approach significantly enhanced the accuracy and efficiency of cervical cancer detection and predictive modelling by adopting advanced machine learning algorithms, such as random forests and support vector machines. The main challenges were the lack of external validation on independent datasets and the need to address model interpretability to ensure healthcare providers understand and trust the predictive models. The study revealed the importance of interdisciplinary collaboration in cervical cancer risk prediction. It made recommendations for future research to focus on increasing the external validation of models, improving model interpretability, and promoting global research collaborations to enhance the comprehensiveness and applicability of cervical cancer risk prediction models.

Prediction of Treatment Recommendations Via Ensemble Machine Learning Algorithms for Non-Small Cell Lung Cancer Patients in Personalized Medicine

Objectives

The primary goal of this research is to develop treatment-related genomic predictive markers for non-small cell lung cancer by integrating various machine learning algorithms that recommends near-optimal individualized patient treatment for chemotherapy in an effort to maximize efficacy or minimize treatment-related toxicity. This research can contribute toward developing a more refined, accurate and effective therapy accounting for specific patient needs.

Methods

To accomplish our research goal, we implement ensemble learning algorithms, bagging with regularized Cox regression models and nonparametric tree-based models via Random Survival Forests. A comprehensive meta-database was compiled from the NCBI Gene Expression Omnibus data repository for lung cancer patients to capture and utilize complex genomic patterns that can predict treatment outcomes more accurately.

Results

The developed novel prediction algorithm demonstrates the ability to support complex clinical decision-making processes in the treatment of NSCLC. It effectively addresses patient heterogeneity, offering predictions that are both refined and personalized in improving the precision of chemotherapy regimens prescribed to the eligible patients.

Conclusion

This research should contribute substantial advancement of cancer treatments by improving the accuracy and efficacy of chemotherapy treatments for a targeted group of patients who need the right treatment. The integration of complex machine learning techniques with genomic data holds substantial potential to transform current cancer treatment paradigms by providing robust support in clinical decision-making.

Survival prediction landscape: an in-depth systematic literature review on activities, methods, tools, diseases, and databases

Survival prediction integrates patient-specific molecular information and clinical signatures to forecast the anticipated time of an event, such as recurrence, death, or disease progression. Survival prediction proves valuable in guiding treatment decisions, optimizing resource allocation, and interventions of precision medicine. The wide range of diseases, the existence of various variants within the same disease, and the reliance on available data necessitate disease-specific computational survival predictors. The widespread adoption of artificial intelligence (AI) methods in crafting survival predictors has undoubtedly revolutionized this field. However, the ever-increasing demand for more sophisticated and effective prediction models necessitates the continued creation of innovative advancements. To catalyze these advancements, it is crucial to bring existing survival predictors knowledge and insights into a centralized platform. The paper in hand thoroughly examines 23 existing review studies and provides a concise overview of their scope and limitations. Focusing on a comprehensive set of 90 most recent survival predictors across 44 diverse diseases, it delves into insights of diverse types of methods that are used in the development of disease-specific predictors. This exhaustive analysis encompasses the utilized data modalities along with a detailed analysis of subsets of clinical features, feature engineering methods, and the specific statistical, machine or deep learning approaches that have been employed. It also provides insights about survival prediction data sources, open-source predictors, and survival prediction frameworks.

Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning

Cervical cancer is a leading cause of women's mortality, emphasizing the need for early diagnosis and effective treatment. In line with the imperative of early intervention, the automated identification of cervical cancer has emerged as a promising avenue, leveraging machine learning techniques to enhance both the speed and accuracy of diagnosis. However, an inherent challenge in the development of these automated systems is the presence of missing values in the datasets commonly used for cervical cancer detection. Missing data can significantly impact the performance of machine learning models, potentially leading to inaccurate or unreliable results. This study addresses a critical challenge in automated cervical cancer identification-handling missing data in datasets. The study present a novel approach that combines three machine learning models into a stacked ensemble voting classifier, complemented by the use of a KNN Imputer to manage missing values. The proposed model achieves remarkable results with an accuracy of 0.9941, precision of 0.98, recall of 0.96, and an F1 score of 0.97. This study examines three distinct scenarios: one involving the deletion of missing values, another utilizing KNN imputation, and a third employing PCA for imputing missing values. This research has significant implications for the medical field, offering medical experts a powerful tool for more accurate cervical cancer therapy and enhancing the overall effectiveness of testing procedures. By addressing missing data challenges and achieving high accuracy, this work represents a valuable contribution to cervical cancer detection, ultimately aiming to reduce the impact of this disease on women's health and healthcare systems.

Enhancing the Accuracy of Lymph-Node-Metastasis Prediction in Gynecologic Malignancies Using Multimodal Federated Learning: Integrating CT, MRI, and PET/CT

Gynecological malignancies, particularly lymph node metastasis, have presented a diagnostic challenge, even with traditional imaging techniques such as CT, MRI, and PET/CT. This study was conceived to explore and, subsequently, to bridge this diagnostic gap through a more holistic and innovative approach. By developing a comprehensive framework that integrates both non-image data and detailed MRI image analyses, this study harnessed the capabilities of a multimodal federated-learning model. Employing a composite neural network within a federated-learning environment, this study adeptly merged diverse data sources to enhance prediction accuracy. This was further complemented by a sophisticated deep convolutional neural network with an enhanced U-NET architecture for meticulous MRI image processing. Traditional imaging yielded sensitivities ranging from 32.63% to 57.69%. In contrast, the federated-learning model, without incorporating image data, achieved an impressive sensitivity of approximately 0.9231, which soared to 0.9412 with the integration of MRI data. Such advancements underscore the significant potential of this approach, suggesting that federated learning, especially when combined with MRI assessment data, can revolutionize lymph-node-metastasis detection in gynecological malignancies. This paves the way for more precise patient care, potentially transforming the current diagnostic paradigm and resulting in improved patient outcomes.